US Patent No: 5,360,894

Number of patents in Portfolio can not be more than 2000

C/EBP2 gene and recombinant C/EBP2

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to a gene which codes for the IL-6 gene expression inducing nuclear factor C/EBP2 capable of binding sequence-specifically to the palindrome structure SEQ ID NO:2 located in the transcriptional regulatory region of the IL-6 gene; an expression plasmid with the C/EBP2 gene incorporated therein; an transformant harboring the expression plasmid; a recombinant C/EBP2 obtained by expressing the C/EBP2 gene; and a method of producing the recombinant C/EBP2.

Loading the Abstract Image... loading....

First Claim

See full text

all claims..

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
TADAMITSU KISHIMOTOTOKYO9

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Akira, Shizuo Osaka, JP 34 53
Hirano, Toshio Osaka-shi, Osaka-fu, JP 40 121
Isshiki, Hiroshi Osaka, JP 6 22
Kinoshita, Shigemi Ibaragi, JP 2 9
Kishimoto, Tadamitsu Tondabayashi, JP 55 541
Shimamoto, Takuya Minoo, JP 2 9
Tanabe, Osamu - 18 84

Cited Art Landscape

  • No Cited Art to Display

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
ISIS PHARMACEUTICALS, INC. (1)
6,271,030 Antisense inhibition of C/EBP beta expression 2 2000
 
SALUTRIA PHARMACEUTICALS LLC (1)
7,071,158 Antioxidant enhancement of therapy for hyperproliferative conditions 2 2001
 
VANDERBILT UNIVERSITY (1)
7,074,399 Treatment of inflammation with p20 0 2001
* Cited By Examiner